BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32382770)

  • 1. Immunodeficiency risk score for prediction of mortality by parainfluenza virus infection in patients with hematologic malignancy.
    Lee J; Jung J; Kim MJ; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Choi EJ; Park HS; Lee JH; Lee JH; Lee KH; Kim SH
    Ann Hematol; 2020 Jun; 99(6):1231-1239. PubMed ID: 32382770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Respiratory syncytial virus and human metapneumovirus after allogeneic hematopoietic stem cell transplantation: Impact of the immunodeficiency scoring index, viral load, and ribavirin treatment on the outcomes.
    Akhmedov M; Wais V; Sala E; Neagoie A; Nguyen TM; Gantner A; von Harsdorf S; Kuchenbauer F; Schubert A; Michel D; Döhner H; Bunjes D
    Transpl Infect Dis; 2020 Aug; 22(4):e13276. PubMed ID: 32162389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parainfluenza virus infections in children with hematologic malignancies.
    Srinivasan A; Wang C; Yang J; Inaba H; Shenep JL; Leung WH; Hayden RT
    Pediatr Infect Dis J; 2011 Oct; 30(10):855-9. PubMed ID: 21540759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parainfluenza virus lower respiratory tract disease after hematopoietic cell transplant: viral detection in the lung predicts outcome.
    Seo S; Xie H; Campbell AP; Kuypers JM; Leisenring WM; Englund JA; Boeckh M
    Clin Infect Dis; 2014 May; 58(10):1357-68. PubMed ID: 24599766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Factors for Parainfluenza Virus Lower Respiratory Tract Disease after Hematopoietic Cell Transplantation.
    Seo S; Xie H; Leisenring WM; Kuypers JM; Sahoo FT; Goyal S; Kimball LE; Campbell AP; Jerome KR; Englund JA; Boeckh M
    Biol Blood Marrow Transplant; 2019 Jan; 25(1):163-171. PubMed ID: 30149147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for mortality after respiratory syncytial virus lower respiratory tract infection in adults with hematologic malignancies.
    Vakil E; Sheshadri A; Faiz SA; Shah DP; Zhu Y; Li L; Kmeid J; Azzi J; Balagani A; Bashoura L; Ariza-Heredia E; Chemaly RF
    Transpl Infect Dis; 2018 Dec; 20(6):e12994. PubMed ID: 30195271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human metapneumovirus infections in hematopoietic cell transplant recipients and hematologic malignancy patients: A systematic review.
    Shah DP; Shah PK; Azzi JM; El Chaer F; Chemaly RF
    Cancer Lett; 2016 Aug; 379(1):100-6. PubMed ID: 27260872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome.
    Nichols WG; Corey L; Gooley T; Davis C; Boeckh M
    Blood; 2001 Aug; 98(3):573-8. PubMed ID: 11468152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parainfluenza virus infections in hematopoietic cell transplant recipients and hematologic malignancy patients: A systematic review.
    Shah DP; Shah PK; Azzi JM; Chemaly RF
    Cancer Lett; 2016 Jan; 370(2):358-64. PubMed ID: 26582658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symptomatic parainfluenza virus infections in children undergoing hematopoietic stem cell transplantation.
    Srinivasan A; Wang C; Yang J; Shenep JL; Leung WH; Hayden RT
    Biol Blood Marrow Transplant; 2011 Oct; 17(10):1520-7. PubMed ID: 21396476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refinement of estimates of mortality risk using the Radiologic Severity Index in hematologic malignancy patients with respiratory syncytial virus infection.
    Sheshadri A; Karimipour M; Vakil E; Bashoura L; Godoy M; Arain MH; Evans SE; Dickey BF; Ost DE; Chemaly RF; Faiz SA
    Transpl Infect Dis; 2019 Aug; 21(4):e13105. PubMed ID: 31081570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parainfluenza virus infections in patients with hematological malignancies or stem cell transplantation: Analysis of clinical characteristics, nosocomial transmission and viral shedding.
    Tabatabai J; Schnitzler P; Prifert C; Schiller M; Weissbrich B; von Lilienfeld-Toal M; Teschner D; Jordan K; Müller-Tidow C; Egerer G; Giesen N
    PLoS One; 2022; 17(7):e0271756. PubMed ID: 35905071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infection.
    Peck AJ; Englund JA; Kuypers J; Guthrie KA; Corey L; Morrow R; Hackman RC; Cent A; Boeckh M
    Blood; 2007 Sep; 110(5):1681-8. PubMed ID: 17502457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The characteristics and outcomes of parainfluenza virus infections in 200 patients with leukemia or recipients of hematopoietic stem cell transplantation.
    Chemaly RF; Hanmod SS; Rathod DB; Ghantoji SS; Jiang Y; Doshi A; Vigil K; Adachi JA; Khoury AM; Tarrand J; Hosing C; Champlin R
    Blood; 2012 Mar; 119(12):2738-45; quiz 2969. PubMed ID: 22246027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local production of inflammatory mediators during childhood parainfluenza virus infection.
    El Feghaly RE; McGann L; Bonville CA; Branigan PJ; Suryadevera M; Rosenberg HF; Domachowske JB
    Pediatr Infect Dis J; 2010 Apr; 29(4):e26-31. PubMed ID: 20182399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multi-drug regimen for respiratory syncytial virus and parainfluenza virus infections in adult lung and heart-lung transplant recipients.
    Liu V; Dhillon GS; Weill D
    Transpl Infect Dis; 2010 Feb; 12(1):38-44. PubMed ID: 19761558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of parainfluenza virus infection in pediatric cancer patients.
    Maeng SH; Yoo HS; Choi SH; Yoo KH; Kim YJ; Sung KW; Lee NY; Koo HH
    Pediatr Blood Cancer; 2012 Oct; 59(4):708-10. PubMed ID: 22095941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upper respiratory viral infections in patients with haematological malignancies after allogeneic haematopoietic stem cell transplantation: a retrospective study.
    Atilla E; Sahin D; Atilla PA; Dolapci I; Tekeli A; Bozdag SC; Yuksel MK; Toprak SK; Ilhan O; Arslan O; Ozcan M; Gurman G; Topcuoglu P
    Antivir Ther; 2018; 23(6):523-527. PubMed ID: 29424696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful Treatment of Parainfluenza Virus Respiratory Tract Infection With DAS181 in 4 Immunocompromised Children.
    Waghmare A; Wagner T; Andrews R; Smith S; Kuypers J; Boeckh M; Moss R; Englund JA
    J Pediatric Infect Dis Soc; 2015 Jun; 4(2):114-8. PubMed ID: 26185620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parainfluenza type 3 infection post stem cell transplant: high prevalence but low mortality.
    Dignan F; Alvares C; Riley U; Ethell M; Cunningham D; Treleaven J; Ashley S; Bendig J; Morgan G; Potter M
    J Hosp Infect; 2006 Aug; 63(4):452-8. PubMed ID: 16772104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.